Crizotinib treatment for refractory pediatric acute myeloid leukemia with RAN-binding protein 2-anaplastic lymphoma kinase fusion gene
Crossref DOI link: https://doi.org/10.1038/bcj.2016.52
Published Online: 2016-08-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hayashi, A
Tanoshima, R
Tsujimoto, S-I
Yanagimachi, M
Takeuchi, M
Sasaki, K
Ikeda, J
Kajiwara, R
Ito, S
Takahashi, H
Text and Data Mining valid from 2016-08-05
Version of Record valid from 2016-08-05
Article History
First Online: 5 August 2016
Competing interests
: The authors declare no conflict of interest.